Bengaluru: repeating that it is “really normal” for the SARS-COV-2 virus, which causes Covid-19, to continue to evolve, and that every variant is concerned (VOC) is only a punctuation in the evolutionary story of the virus.
, Scientists say ‘BA’s newest’.
2 ‘Sub-Lineage may not cause improper concern.
Prof.
Seshadri Vasan, COVID-19 CSIRO CSIRO project leader and an expert on how the virus has developed, said: “The latest Lineage VOC Omicron B.
1.
529, which comes from specimens collected on November 9, 2021, including three subleats BA.
1, BA.
2 and BA.
3, but this should not cause improper concern.
“Shows Ba.
2 (short for “B.
1.
1.
529.
2), share mutations 32 with original Omicron genealogy lines BA.
1 (short for B.
1.
1.
529.
1), including the mutation of the famous surge such as N501Y, P681H and D614G, said Vasan, there are also 28 different mutations.
“In particular, BA.
2 Does not have the elimination of the ’69 -70 ‘surge present at Omicron BA.
1 and Alpha VOC.
Good BA.
1 and BA.
2 The lack of mutation of the L452R and P681R surge which is the characteristic of Delta VOC.
This property is useful for distinguishing between various variants and sub-linings using existing sequencing technology, “Vasan said.
CSIRO analysis of the global repository – GISAID – shows that on January 28, 18,751 BA.
2 sequences have been reported from all over the world and 91% of The order of three countries: Denmark (14,371), England (1,371) and India (1,249).
“Globally, researchers, including my team in CSIRO, are studying the properties of this sub-genealogy compared to Omicron BA.
1 and delta to see for example if it is more contagious, or will lead to the runaway of immune or disease that is more severe, “Vasan said.” So far, the evidence of our colleagues in Denmark shows that while it can spread faster, there is no evidence of increased severity .
Therefore, it is important to stay calm and continue the steps that exist like get vaccinations, including booster doses, and after social blasphemy, masks and local locking guides.
“The Vasal team has collaborated with the Bengaluru-based Indian Science Institute, and has shown that the ‘Mynvax’ NextGeneration ‘vaccine of the Institute applies to Alpha, Beta, Gamma and Delta VOC.” We currently repeat this evaluation of Omicron, “added Vasan .
Also, the team is in the midst of a $ 1 initiative ‘system’ 7 million to identify promising drug covid approved for several other indications.
“We will evaluate our major candidates against Delta and BA.
1 and BA.
2 Omicron sub-lineages, “he said, adding that this project has global partners including pharmaceuticals and engine learning professors from Bits Pilani India.